Poly-L-lactic Acid (PLLA)-Chitosan-Collagen Electrospun Tube for Vascular Graft Application
Source abstract
Abstract
Poly-L-Lactic acid (PLLA) blended with chitosan and collagen was used to fabricate a conduit for blood vessel engineering through an electrospinning process. Various concentrations of chitosan were used in the blend in order to study its effect on the morphology, chemical bond, tensile strength, burst pressure, hemocompatibility, and cell viability (cytotoxicity) of the tube.In vitro assessments indicated that addition of chitosan-collagen could improve cell viability and hemocompatibility. Best results were demonstrated by the conduit with 10% PLLA, 0.5% chitosan, and 1% collagen. Tensile strength reached 2.13 MPa and burst pressure reached 2593 mmHg, both values that are within the range value of native blood vessel. A hemolysis percentage of 1.04% and a cell viability of 86.2% were obtained, meeting the standards of high hemocompatibility and low cytotoxicity for vascular graft material. The results are promising for further development toward vascular graft application.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Biomedical Engineering, Faculty of Science and Technology, Universitas Airlangga, Jawa Timur 60115, Indonesia
Institute of Tropical Disease, Universitas Airlangga, Jawa Timur 60115, Indonesia
References (19)
Show source-provided references
1. Mechanisms of plaque formation and rupture10.1161/CIRCRESAHA.114.302721 ↗
2. Porous nanofibrous PLLA scaffolds for vascular tissue engineering10.1016/j.biomaterials.2010.07.028 ↗
3. Mechanical property characterization of electrospun recombinant human tropoelastin for vascular graft biomaterials10.1016/j.actbio.2011.08.001 ↗
4. Biomaterials for vascular tissue engineering10.2217/rme.09.77 ↗
5. Tintoiu, I.C., Underwood, M.J., Cook, S.P., Kitabata, H., and Abbas, A. (2016). Bioresorbable Vascular Scaffolds in the Treatment of Coronary Artery Bypass Grafts. Coronary Graft Failure: State of the Art, Springer International Publishing.
6. Martínez, J., Falomir, M., and Gozalbo, D. (2014). Chitin: A structural biopolysaccharide with multiple applications. eLS.10.1002/9780470015902.a0000694.pub3 ↗
7. Collagen as an implantable material in medicine and dentistry10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2 ↗
8. Electrospinning collagen/chitosan/poly(L-lactic acid-co-ϵ-caprolactone) to form a vascular graft: Mechanical and biological characterization
9. Coates, J. (2000). Interpretation of Infrared Spectra, A Practical Approach. Encyclopedia of Analytical Chemistry, John Wiley & Sons, Ltd.10.1002/9780470027318.a5606 ↗
10. Coronary artery dimensions in normal Indians10.1016/j.ihj.2017.01.009 ↗
11. Wilson, S.E. (2010). Vascular Access: Principles and Practice, Lippincott Williams & Wilkins.
12. Measurement of the uniaxial mechanical properties of healthy and atherosclerotic human coronary arteries10.1016/j.msec.2013.02.016 ↗
13. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery10.1016/j.biomaterials.2008.11.011 ↗
14. The ECVAM international validation study on in vitro tests for acute skin irritation: Report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test10.1177/026119290703500614 ↗
15. Biomaterials in the development and future of vascular grafts10.1067/mva.2003.88 ↗
16. Electrospinning and mechanical characterization of gelatin nanofibers10.1016/j.polymer.2004.04.005 ↗
17. Mechanical properties of tissue-engineered vascular constructs produced using arterial or venous cells10.1089/ten.tea.2010.0613 ↗
18. Basic Colorimetric Proliferation Assays: MTT, WST; Resazurin10.1007/978-1-4939-6960-9_1 ↗
19. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs